Loading clinical trials...
Loading clinical trials...
Phase 2 Study of Therapeutic Effect and Safety of Combined Hydroxyurea With Recombinant Human Erythropoietin.
Conditions
Interventions
Hydroxyurea ,Epiao
hydroxyurea, blood transfusion
Locations
1
Egypt
hematology clinic ,pediatrics hospital, Ain Shams University hospital
Cairo, Egypt
Start Date
June 1, 2012
Primary Completion Date
December 1, 2012
Completion Date
December 1, 2012
Last Updated
June 20, 2012
NCT06931912
NCT05444894
NCT06831799
NCT05883254
NCT03993613
NCT01496963
Lead Sponsor
Ain Shams University
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions